This Article Free upon publication Full Text Full Text (PDF) Data Supplement All Versions of this Article: 50/1/69    most recent HYPERTENSIONAHA.107.088591v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, D. Articles by Paterson, D. J. Search for Related Content PubMed PubMed Citation Articles by Li, D. Articles by Paterson, D. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Related Collections Animal models of human disease Other hypertension Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2007;50:69.)
© 2007 American Heart Association, Inc.

Original Articles

Noradrenergic Cell Specific Gene Transfer With Neuronal Nitric Oxide Synthase Reduces Cardiac Sympathetic Neurotransmission in Hypertensive Rats

Dan Li; Lijun Wang; Chee-Wan Lee; Tom A. Dawson; David J. Paterson

From the Burdon Sanderson Cardiac Science Centre, Department of Physiology, Anatomy & Genetics, Oxford, UK.

Correspondence to David J. Paterson DPhil, DSc, Department of Physiology, Anatomy, and Genetics, Sherrington Building, Parks Road, Oxford, UK OX1 3PT. E-mail david.paterson{at}physiol.ox.ac.uk

Nitric oxide–cGMP pathway can inhibit cardiac norepinephrine (NE) release. Sympathetic hyper-responsiveness in hypertension may result from oxidative stress impairing this pathway. We tested the hypothesis that the gene transfer of neuronal NO synthase (nNOS) could restore sympathetic balance in the spontaneously hypertensive rat (SHR). An adenovirus (5x10¹⁰ particles) constructed with a noradrenergic neuron-specific promoter (PRS x8) encoding nNOS (Ad.PRS-nNOS) or enhanced green fluorescence protein (Ad.PRS-eGFP) was targeted to the right atrial wall by percutaneous injection in age-matched male SHRs and Wistar-Kyoto (WKY) rats. Five days after transduction, right atria were removed, and evoked [³H] norephinephrine (NE) release, NOS activity, and cGMP were measured. In the Ad.PRS-eGFP treated group, tissue levels of cGMP were significantly lower in the SHR compared with the WKY atria. NE release was also greater in the SHR, and soluble guanylate cyclase inhibition did not alter evoked [³H] NE release in the Ad.PRS-eGFP–treated SHR. All atria treated with Ad.PRS-nNOS had enhanced nNOS activity when compared with Ad.PRS-eGFP atria. Ad.PRS-nNOS in WKY rats reduced NE release compared with the Ad.PRS-eGFP group. Guanylate cyclase inhibition enhanced NE release in both Ad.PRS-nNOS– and Ad.PRS-eGFP–treated WKY atria. Ad.PRS-nNOS restored cGMP levels in the SHR to those seen in the WKY atria. In the SHR, Ad.PRS-nNOS also attenuated NE release compared with Ad.PRS-eGFP group. This was reversed by guanylate cyclase inhibition. We conclude that artificial upregulation of sympathetic nNOS via gene transfer with a noradrenergic promoter may provide a novel approach for correcting peripheral sympathetic hyperactivity in hypertension.

Key Words: nitric oxide • gene transfer • autonomic nervous system • norepinephrine • hypertension • cyclic GMP

This article has been cited by other articles:

				J. K. Choate, S. M. Murphy, R. Feldman, and C. R. Anderson Sympathetic control of heart rate in nNOS knockout mice Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H354 - H361. [Abstract] [Full Text] [PDF]

				N. Herring and D. J Paterson Letter by Herring and Paterson Regarding Article, "Common NOS1AP Variants Are Associated With a Prolonged QTc Interval in the Rotterdam Study" Circulation, December 11, 2007; 116(24): e564 - e564. [Full Text] [PDF]